Clinical Immunology, Neuropharmacology and Drug Development

Advances in Immuno-Oncology for CNS Tumors

This track invites abstracts on the latest developments in immuno-oncology for central nervous system (CNS) tumors. Researchers should focus on novel immunotherapeutic approaches, including immune checkpoint inhibitors, CAR-T cell therapy, and vaccines targeting CNS malignancies. Submissions that address the unique challenges of treating brain tumors, such as the blood-brain barrier and tumor microenvironment, are highly encouraged. Attendees will learn about the cutting-edge research that is driving new treatment options for CNS tumors, offering hope for improved outcomes in this challenging field.